ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

8,648Medicare Part D Prescriptions Filled, Including Refills

Rank: 150 out of 1006

$504K Total Retail Price of All Prescriptions

Rank: 221 out of 1006

380 Patients Receiving at Least One Drug in Part D
93%Patients 65 Years and Older
60% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in Connecticut
Lower avg

Schedule Two
Controlled Substances

3% of this provider’s 380 patients filled at least one prescription for a schedule two drug, compared to an average of 4%.

Schedule Three
Controlled Substances

N/A

Risky Drugs to Seniors

1% of this provider’s 8,193 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

24% of this provider’s prescriptions were for brand-name drugs, compared to an average of 29%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $71 among peers.

Prescriptions per Patient

23 is the average number of prescriptions (including refills) per patient, compared to an average of 18.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in Connecticut
AMLODIPINE BESYLATE 481 466 1 4
LISINOPRIL 387 358 2 3
SIMVASTATIN 351 329 3 1
FUROSEMIDE 309 301 4 6
PRAVASTATIN SODIUM 289 270 5 15
METOPROLOL TARTRATE 278 276 6 7
LEVOTHYROXINE SODIUM 206 206 7 2
WARFARIN SODIUM 197 197 8 8
DONEPEZIL HCL 143 143 9 17
HYDROCHLOROTHIAZIDE 140 140 10 11
METFORMIN HCL 137 132 11 10
CITALOPRAM HBR 137 129 11 24
ATORVASTATIN CALCIUM 129 127 13 5
TRAZODONE HCL 119 119 14 21
METOPROLOL SUCCINATE 117 112 15 12
NAMENDA 101 101 16 34
MIRTAZAPINE 99 99 17 26
QUETIAPINE FUMARATE 99 96 17 45
OMEPRAZOLE 98 95 19 9
ALENDRONATE SODIUM 92 92 20 29
GABAPENTIN 90 83 21 20
DIOVAN 90 85 21 16
PREDNISONE 89 87 23 33
TAMSULOSIN HCL 85 38 24 23
LOSARTAN POTASSIUM 84 84 25 22
ZOLPIDEM TARTRATE 83 61 26 14
SERTRALINE HCL 78 78 27 19
EXELON 75 75 28 99
ESCITALOPRAM OXALATE 75 73 28 27
PAROXETINE HCL 75 63 28 62
ATENOLOL 73 73 31 13
ADVAIR DISKUS 69 58 32 37
CLOZAPINE 65 65 33 107
DILTIAZEM 24HR CD 62 62 34 88
POTASSIUM CHLORIDE 62 62 34 30
RANITIDINE HCL 57 57 36 63
JANUVIA 55 55 37 49
CYMBALTA 54 42 38 41
ALLOPURINOL 54 54 38 31
CRESTOR 54 54 38 18
AZITHROMYCIN 51 48 41 39
GLIPIZIDE 50 50 42 69
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on July 1, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.